GLP-1 Receptor Agonist Research
An overview of GLP-1 receptor agonist peptides — including incretin signaling mechanisms, dual and triple agonist research, and the evolution toward compounds like GLP-3RT (Retatrutide) that target GLP-1, GIP, and glucagon receptors simultaneously.
All Alpha Tides compounds including GLP-3RT are for in-vitro laboratory research only. Not for human or animal consumption. All information below is sourced from published preclinical and clinical literature.
What Is GLP-1?
Glucagon-Like Peptide-1 (GLP-1) is an incretin hormone produced by L-cells in the gut in response to food ingestion. It plays a central role in blood glucose regulation by stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and signaling satiety via central nervous system pathways.
Native GLP-1 has an extremely short half-life of approximately 2 minutes due to rapid degradation by the enzyme DPP-4 (dipeptidyl peptidase-4). This has driven extensive pharmaceutical research into GLP-1 analogs and receptor agonists engineered for extended half-lives.
Mechanism of Action
GLP-1 Receptor Signaling
GLP-1 receptor agonists bind to the GLP-1R (a G-protein coupled receptor) and activate intracellular cAMP signaling, which drives:
- Glucose-dependent insulin secretion — GLP-1R activation in pancreatic beta cells stimulates insulin release in a glucose-dependent manner in preclinical models, a mechanism studied for its relationship to hypoglycemia in metabolic research
- Glucagon suppression — Inhibition of alpha-cell glucagon secretion reduces hepatic glucose output
- Gastric emptying delay — Slowed gastric motility reduces post-meal glucose spikes
- CNS receptor signaling — GLP-1R expression in the hypothalamus and brainstem has been investigated in preclinical models for its role in satiety pathway modulation
From Single to Triple Agonism
Research in the incretin space has evolved rapidly from single GLP-1R agonism toward dual and triple receptor agonism, reflecting growing understanding of the complementary roles of GLP-1, GIP, and glucagon pathways in metabolic regulation.
| Generation | Targets | Research Focus |
|---|---|---|
| Single Agonist | GLP-1R | Glucose regulation, insulin secretion |
| Dual Agonist | GLP-1R + GIPR | Metabolic + adipose research |
| Triple Agonist | GLP-1R + GIPR + GCGR | Comprehensive metabolic research — GLP-3RT (Retatrutide) |
GLP-3RT (Retatrutide) — Triple Receptor Agonist
GLP-3RT (Retatrutide) is Alpha Tides' triple receptor agonist compound for research use. Retatrutide targets GLP-1, GIP, and glucagon receptors simultaneously — representing the current frontier of incretin-based research. This triple agonism is of particular interest to researchers studying the interaction between:
- GLP-1R activation and insulin secretion
- GIPR activation and its synergistic effects on GLP-1 signaling and adipose tissue
- Glucagon receptor activation and hepatic glucose output / energy expenditure
| Property | GLP-3RT (Retatrutide) |
|---|---|
| Receptor Targets | GLP-1R, GIPR, GCGR (triple agonist) |
| Approximate Half-Life | ~6 days |
| Structural feature | C18 fatty acid conjugation for albumin binding and extended half-life |
| Administration frequency in published preclinical studies | Once weekly typical (SC, published studies) |
| Form (Alpha Tides) | Lyophilized powder |
Reconstitution & Research Preparation
GLP-3RT from Alpha Tides is supplied as lyophilized powder and must be reconstituted with bacteriostatic water before use. See the Peptide Reconstitution Guide for protocol details, the Peptide Calculator for draw volume calculations, and the Peptide Dosage Chart for published dosage ranges.
GLP-3RT's ~6-day half-life means that once-weekly administration schedules are common in published preclinical studies. Do not confuse long half-life with long reconstituted storage stability — see the Peptide Storage Guide for storage requirements.
This material is intended for laboratory research purposes only. Not for human consumption, clinical use, or diagnostic use. Products are not intended to diagnose, treat, cure, or prevent any disease.
Shop Research Compounds
All compounds available at alphatideshop.com — third-party tested, USA based.